| abstract |
The present invention provides novel quinazolinone compositions of matter comprising enantiomerically pure compound represented by Formula I: n nor a pharmaceutically acceptable salt thereof, having a detectable amount of one or more starting material and/or reagent used in the synthesis thereof. |